Every round on record, with the sources behind each and the investors on them.
A company at the intersection of AI, robotics and medicine
chemify.ioLinkedInGlasgow, ScotlandMedtechOver 200 employees
1 source
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The source identifies Chemify as a University of Glasgow spinout but does not state its headquarters. BlueYard Capital is described as an existing investor participating alongside the new investors.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series A [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $43M | 2023-08-03 | Triatomic | No recent discussion |
1 source [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 source The source identifies Chemify as a University of Glasgow spinout but does not state its headquarters. BlueYard Capital is described as an existing investor participating alongside the new investors. | ||||
Chemify combines AI, robotics, computation and a chemical programming language to design and make molecules for pharmaceutical, biotech, industrial and materials-science partners.
Checked against 8 sources on Sep 26
| EARLIER ROUNDS FROM COMPANY RESEARCH · DEVELOPING | ||||
| Series B | over $50 million | 2025-10-21 | Wing Venture Capital, Insight Partners | |
Also named as backers in company research: Wing Venture Capital, Insight Partners, 8VC, Rockspring, David Cleevely, Scottish Enterprise